Peptide and Anticoagulant Drugs Market projected to reach $173.99 billion by 2032, driven by growth factors
From GlobeNewswire: 2025-04-22 08:45:00
The Peptide and Anticoagulant Drugs Market is projected to reach USD 173.99 billion by 2032, growing at a CAGR of 7.24%. The market is driven by the rise in chronic disorders and advancements in drug delivery and peptide synthesis technologies. The U.S. market is expected to reach USD 52.61 billion by 2032, led by sophisticated healthcare infrastructure and strong R&D spending.
Key companies in the market include Bristol-Myers Squibb, Pfizer, Bayer, Janssen Pharmaceuticals, and Boehringer Ingelheim. The parenteral segment dominates the market with 28.36% market share, favored for acute and chronic diseases. Anticoagulant drugs segment is expected to grow at the fastest rate due to the rising incidence of cardiovascular diseases and stroke.
Hospitals and clinics are the dominant end-users of Peptide and Anticoagulant Drugs, accounting for 46.15% market share in 2023. North America leads the market with 40.13% market share in 2023, driven by pharmaceutical manufacturing capabilities and enhanced regulatory pathways. Asia Pacific is expected to register the fastest growth in the market.
Overall, the Peptide and Anticoagulant Drugs Market is experiencing high growth due to factors like the aging population, rising chronic disorders, and technological advancements in drug delivery. The market is expected to continue growing, driven by increased demand for anticoagulant therapies and peptide-based treatments. The Peptide and Anticoagulant Drugs Market in Asia Pacific is projected to grow at a rapid pace of 8.34% CAGR, driven by factors such as increasing healthcare awareness, a rising elderly population, and a growing burden of thrombotic disorders. The biopharmaceutical sector’s expansion, supportive government policies, and improved healthcare access contribute to this growth.
Key points in the research methodology of the Peptide and Anticoagulant Drugs Market include an impact analysis on market dynamics, statistical insights and trends reporting, incidence, and prevalence data for 2023, prescription trends, healthcare spending breakdown by region, regulatory approvals and pipeline drugs forecast, treatment adherence rates, and a competitive landscape overview.
The market analysis covers different aspects such as the route of administration, application, and end-users of Peptide and Anticoagulant Drugs. It also includes regional analysis, company profiles, use cases, and best practices. Related reports by SNS Insider provide insights into the Biopharmaceuticals Market, Anticoagulation Market Outlook, Venous Thromboembolism Treatment Market Trends, Drug Delivery Systems Market, and Diabetes Drug Market Growth Report.
SNS Insider is a top market research and consulting agency globally, dedicated to providing clients with up-to-date market data, consumer insights, and opinions to make confident decisions in a changing environment. Their research techniques include surveys, video talks, and focus groups worldwide to deliver accurate and current information.
Read more at GlobeNewswire: Peptide and Anticoagulant Drugs Market Size to Hit USD